Serum concentration of asprosin in new-onset type 2 diabetes

BACKGROUND: Asprosin, a newly identified adipokine, is pathologically increased in individuals with insulin resistance. However, the available evidence on the association of asprosin and type 2 diabetes mellitus (T2DM) status is still scarce. Therefore, this study aimed to determine the relationship...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetol Metab Syndr
Main Authors: Naiemian, Shakiba, Naeemipour, Mohsen, Zarei, Mehdi, Lari Najafi, Moslem, Gohari, Ali, Behroozikhah, Mohammad Reza, Heydari, Hafez, Miri, Mohammad
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7376837/
https://ncbi.nlm.nih.gov/pubmed/32714446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-020-00564-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados